Echinacea Not the Miracle Drug for Tomorrow

Download Report

Transcript Echinacea Not the Miracle Drug for Tomorrow

Echinacea
Not the Miracle Drug for
Tomorrow
Teresa Cantwell
Issues of Science and Technology
Nora Demers
The Issue
 Today,
there is not enough research done
on nutraceuticals, such as Echinacea, to
be readily available to the public.
 Nutraceuticals
 FDA
 Echinacea
Nutraceuticals
 What



is it?
Combination between pharmaceuticals and
nutrition
“any substance that is a food or a part of a
food and provides medical or health benefits,
including the prevention and treatment of
disease.”
American Nutraceutical Association
Popularity


This chart shows the demand for nutraceuticals in the
United States (even without regulation)
According to American Chemistry
The Food and Drug Administration
 The
FDA started in 1962 and it wasn’t until
1994 (Clinton Administration) that they
started to address dietary supplements
and nutracetucials.
 The FDA places regulations on food and
drugs for the U.S.
 FDA
Dietary Supplement Health and
Education Act
 1994
President Bill Clinton
 FDA no longer has responsibility, the
companies putting the drugs on the shelf
are responsible for them
 Problem: The public is unaware of the lack
of FDA approval and is often mislead by
the drug company’s marketing
Labeling
 “This
statement has not been evaluated by
the Food and Drug Administration. This
product is not intended to diagnose, treat,
cure, or prevent any disease.”
 Although items are marketed as one thing,
this statement is used as a disclaimer
How to get a drug passed through
the FDA
 Three
step process costing approximatly
$300 Million
 This all depends on the type of drug up for
application
 For a general drug: Review Process
Echinacea

Purple Cone Flowerseveral different forms
used within the medical
field
 E. purpurea, and
Echinacea angustifolia
are the most popular
forms used for colds and
immune systems
 According to: American
Family Physical
History
 Began
with Native Americans using it for
things such as colds, coughs, sore throats,
infections, and veterinary needs.
 1762- John Clayton learned about the
herb and brought it back to Europe
 The Herb flourished in the U.S., as well as
in Europe (Germany) where the herb is
still remains popular today.
History…

1887- Echinacea began its official use in the
medical practice.
 1930-The FDA releases information stating that
there is no affect on the immune system from
Echinacea: popularity decreases in the US, but
remains in Europe still today.
 2002- Studies show that retailers sold
approximately $58 million in Echinacea products
Echinacea Today

Since the 1930 nothing has been done in the
United States as far as research on Echinacea
until today
 Studies show now that the two most popular
forms of Echinacea do nothing for a humans
immune system
 Studies also found that 483 people had bad
reactions, 33 people were hospitalized, and one
person who experienced a life threatening
reaction Hurley, 2007
Echinacea

Germany Studies found that:




People with any kind of autoimmune disease should
not be taking Echinacea.
It is also found that there is not a standardized
answer to Echinacea because there are so many
types
www.aafp.org/afp/20030101/77/html
Science Daily:


“can trigger immunosuppressant, causing poor would
healing and infection” – in regards to surgery
http://www.sciencedaily.com/releases/2006/02/06021
4225847.htm
Negative Findings
 The

News-Press:
“The federal government’s National Center for
Complementary and Alternative medicine
says scientific studies indicate that Echinacea
doesn’t appear to prevent colds, nor does it
shorten their duration.”
Who is Responsible?
 Consumers?


Not reading the labels
Not being informed
 FDA?

Not taking responsibility
 Drug


Companies?
Mis-marketing
Not informing the public
Video on Echinacea
Echinacea
Solution
 Everyone
is responsible: I believe now that
the best way to solve this issue is to make
small changes everywhere:



Consumers need to read the labels, as well
as read up on drugs they are taking.
The FDA needs to create new regulations that
puts these nutraceuticals in a new category.
Drug Companies need to properly market
their products.